Porcine circovirus (PCV) presents a significant swine disease challenge, says the Swine Health Information Center (SHIC). That's why it is included in SHIC’s 2024 Plan of Work as a priority pathogen.
SHIC, along with the American Association of Swine Veterinarians, recently held a webinar focused on emerging trends of porcine circovirus. Expert presenters provided the latest information on porcine circovirus including domestic and global distribution, new research updates, diagnostic trends, sample types submitted for surveillance, interpretation of test results and practitioner perspectives for disease management strategies.
Tanja Opriessnig of Iowa State University provided a general disease overview including domestic and global distribution, recent research outcomes and an update on PCV4. She said although PCVs were first identified approximately 27 years ago, an improved understanding of circoviruses and their impact on swine health has continued to evolve over time.
"PCV2 has been a significant health challenge for global pig producers for many decades. Dr. Opriessnig said PCV2-specific vaccines have worked remarkably well to prevent viral health impacts since global introduction in 2006. Modern PCV2 vaccines provide cross-protection against currently known PCV2 genotypes and are among the most widely used vaccine in growing pigs. Dr. Opriessnig shared evidence of the global distribution of PCV3 as well as the recent identification of PCV4 in Asia and Spain, saying a more field-based approach is needed for prevention, preparedness, and response to emerging PCVs. Dr. Opriessnig remarked that initial evidence shows that PCV3 vaccines are helpful for control and that monitoring for emerging strains, including porcine circovirus-like viruses, is ongoing," SHIC reports in its latest newsletter.